Calcium Administration in Life-saving Management During Massive Hemorrhage

PHASE2/PHASE3Not yet recruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

May 1, 2025

Primary Completion Date

April 30, 2026

Study Completion Date

May 31, 2026

Conditions

Massive HemorrhageTraumaHypocalcemia

Interventions

DRUG

calcium gluconate

3g IV or IO calcium gluconate.

DRUG

Control: Placebo

3g of IV or IO saline placebo.

All Listed Sponsors

lead

London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's

OTHER

NCT06820645 - Calcium Administration in Life-saving Management During Massive Hemorrhage | Biotech Hunter | Biotech Hunter